Sofia Borges, Nuno Menezes, Catarina Silva, & Tiago Torres. (2018). Adalimumab in the treatment of moderate-severe hidradenitis suppurativa: A cost-effectiveness analysis. Formifarma, LDA..
Chicago Style (17th ed.) CitationSofia Borges, Nuno Menezes, Catarina Silva, and Tiago Torres. Adalimumab in the Treatment of Moderate-severe Hidradenitis Suppurativa: A Cost-effectiveness Analysis. Formifarma, LDA., 2018.
MLA (9th ed.) CitationSofia Borges, et al. Adalimumab in the Treatment of Moderate-severe Hidradenitis Suppurativa: A Cost-effectiveness Analysis. Formifarma, LDA., 2018.
Warning: These citations may not always be 100% accurate.